Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body’s internal organs. Its most common site is the pleura, but it may also occur in the peritoneum or the pericardium.
NIH-funded researchers discover genetic link to mesothelioma — Identified gene mutation may underlie other cancer types – Individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer ? mesothelioma, and melanoma of the eye. Mesothelioma tumors are typically associated with asbestos and erionite exposure.
U.S. Food and Drug Administration (FDA) approves first maintenance drug therapy for advanced lung cancer — Alimta, pemetrexed. – Eli Lilly’s lung cancer drug Alimta (pemetrexed) — the first drug available for maintenance therapy of advanced or metastatic lung cancer, is approved by the U.S. Food and Drug Administration, USA.
Unite the union has successfully defended the rights of vulnerable asbestos victims from insurers’ attempts to avoid their liabilities. – In a landmark test case in the High Court, Unite the union, has successfully defended the rights of vulnerable asbestos victims from insurers’ attempts to avoid their liabilities.
First-line chemotherapy regimen showed clinically relevant survival differences in specific histology types of advanced non-small cell lung cancer. – Eli Lilly and Company (NYSE: LLY) announced that it received approval from the U.S. Food and Drug Administration (FDA) for the use of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, in the first-line treatment of locally-advanced and metastatic non-small cell lung cancer (NSCLC), for patients with nonsquamous histology.
